Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson’s Disease
Authors:
- 17 September 2019
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Neurovascular Research
- Vol. 16 (3) , 241-249
Abstract
Objective: Recent studies suggest that not only is constipation a clinical marker of premotor phase in Parkinson’s Disease (PD), but is also correlated with the duration and severity. Some reports indicated that inflammatory from gut dysbiosis might be involved in the pathogenesis of PD, but the correlation between them remains poorly understood. This study aims to investigate how the presence of constipation affects the dopamine level of nigrostriatal system and whether gastrointestinal (GI) inflammation is involved in the brain-gut axis. Methods: Clinical materials, serum inflammatory factors, and datum of dopamine level including 84 cases and 83 controls, were collected consecutively and randomly from November 1, 2017 to October 31, 2018. Dopamine levels of nigrostriatal system were detected by [18F]-DTBZ radiotracer (18F-AV-133). Data analysis was conducted by variance, covariance analysis, bicorrelation, partial correlation, chi-square analysis and logistic regression. Results: The mean age of cases was older than that of controls, and male predominance was also observed (P<0.05). The mean scores of Hoehn-Yahr and unified Parkinson’s disease rating scale Ⅲ (UPDRS-Ⅲ) were of significantly different duration between two groups (P0.05). The dopamine levels of putamen and caudate nucleus, especially in the dorsal part of putamen, were significantly decreased in cases than that in controls (P<0.05). There were significant differences of complement 3 (C3) and complement 4 (C4) between cases and controls (P<0.05). Dopamine levels in putamen and caudate nucleus were negatively correlated with serum concentrations of immunoglobulin A (IgA), immunoglobulin G (IgG) and C3 in cases (P0.05). Conclusion: The presence of constipation may increase the severity of motor symptoms and decrease dopamine levels of nigrostriatal system in PD. Inflammatory factors may be involved in the brain-gut axis of PD.Keywords
Funding Information
- National Natural Science Foundation of China (30970926)
- Foundation Clinical Research of Capital Medical University (14JL19)
This publication has 40 references indexed in Scilit:
- Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptomsJournal of Neurology, 2012
- Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System AtrophyThe American Journal of Pathology, 2011
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with SymptomsPLOS ONE, 2010
- Protective role of interlekin-1 alpha gene polymorphism in Chinese Han population with sporadic Parkinson’s diseaseNeuroscience Letters, 2008
- Genetic association between low-density lipoprotein receptor-related protein gene polymorphisms and Alzheimer's disease in Chinese Han populationNeuroscience Letters, 2008
- Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicityBrain Research, 2007
- Parkinson disease IgG and C5a-induced synergistic dopaminergic neurotoxicity: Role of microgliaNeurochemistry International, 2007
- Constipation in parkinson's disease: Objective assessment and response to psylliumMovement Disorders, 1997
- Gastrointestinal symptoms in parkinson disease: 18‐month follow‐up studyMovement Disorders, 1993